Elizabeth S. Inks

813 total citations
14 papers, 694 citations indexed

About

Elizabeth S. Inks is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Elizabeth S. Inks has authored 14 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Elizabeth S. Inks's work include Histone Deacetylase Inhibitors Research (11 papers), Peptidase Inhibition and Analysis (9 papers) and Protein Degradation and Inhibitors (9 papers). Elizabeth S. Inks is often cited by papers focused on Histone Deacetylase Inhibitors Research (11 papers), Peptidase Inhibition and Analysis (9 papers) and Protein Degradation and Inhibitors (9 papers). Elizabeth S. Inks collaborates with scholars based in United States and China. Elizabeth S. Inks's co-authors include C. James Chou, Benjamin J. Josey, Yingjie Zhang, Xiaoyang Li, Yuri K. Peterson, Jiaying Li, Wenfang Xu, Cheng Zhang, Jesse J. McClure and Xuejun Wen and has published in prestigious journals such as Neuroscience, Journal of Medicinal Chemistry and RSC Advances.

In The Last Decade

Elizabeth S. Inks

14 papers receiving 685 citations

Peers

Elizabeth S. Inks

ONCOL

PHARM

TOXIC

Eric Ferrandis France

Atul D. Jain United States

Rebecca Kinkade United States

Esther Marco Spain

Dominique Swinnen Belgium

Carole Grasso New Zealand

Andrea Coletta Italy

J. Elizabeth Pease United Kingdom

Brent Douty United States

Xuemei Deng China

Eric Ferrandis France

Elizabeth S. Inks

412 ×0.8

137 ×0.6

ONCOL

320 ×1.5

37 ×0.7

PHARM

39 ×0.8

TOXIC

Citations per year, relative to Elizabeth S. Inks Elizabeth S. Inks (= 1×) peers Eric Ferrandis

Countries citing papers authored by Elizabeth S. Inks

Since Specialization

Citations

This map shows the geographic impact of Elizabeth S. Inks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth S. Inks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth S. Inks more than expected).

Fields of papers citing papers by Elizabeth S. Inks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth S. Inks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth S. Inks. The network helps show where Elizabeth S. Inks may publish in the future.

Co-authorship network of co-authors of Elizabeth S. Inks

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth S. Inks. A scholar is included among the top collaborators of Elizabeth S. Inks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth S. Inks. Elizabeth S. Inks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Xiaoyang, Yuqi Jiang, Yuri K. Peterson, et al.. (2020). Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. Journal of Medicinal Chemistry. 63(10). 5501–5525. 57 indexed citations

Li, Xiaoyang, Yuri K. Peterson, Elizabeth S. Inks, et al.. (2018). Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. Journal of Medicinal Chemistry. 61(6). 2589–2603. 70 indexed citations

Zhao, Chunlong, Jie Zang, Elizabeth S. Inks, et al.. (2018). Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors. European Journal of Medicinal Chemistry. 150. 282–291. 31 indexed citations

Li, Xiaoyang, Yingjie Zhang, Yuqi Jiang, et al.. (2017). Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study. European Journal of Medicinal Chemistry. 134. 185–206. 32 indexed citations

McClure, Jesse J., Elizabeth S. Inks, Cheng Zhang, et al.. (2017). Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs. ACS Chemical Biology. 12(6). 1644–1655. 42 indexed citations

McClure, Jesse J., Cheng Zhang, Elizabeth S. Inks, et al.. (2016). Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 59(21). 9942–9959. 88 indexed citations

Duan, Wenwen, Jin Li, Elizabeth S. Inks, et al.. (2015). Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor. Journal of Medicinal Chemistry. 58(10). 4325–4338. 82 indexed citations

Li, Xiaoyang, Elizabeth S. Inks, Xiaoguang Li, et al.. (2014). Discovery of the First N-Hydroxycinnamamide-Based Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor Activity. Journal of Medicinal Chemistry. 57(8). 3324–3341. 72 indexed citations

Rahn, Jennifer J., Jennifer E. Bestman, Benjamin J. Josey, et al.. (2013). Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy. Neuroscience. 259. 142–154. 39 indexed citations

10.

Zhang, Lei, Yingjie Zhang, C. James Chou, et al.. (2013). Histone Deacetylase Inhibitors with Enhanced Enzymatic Inhibition Effects and Potent in vitro and in vivo Antitumor Activities. ChemMedChem. 9(3). 638–648. 21 indexed citations

11.

Zhang, Yingjie, Elizabeth S. Inks, Mengyuan Zhu, et al.. (2013). Discovery of a pair of diastereomers as potent HDACs inhibitors: determination of absolute configuration, biological activity comparison and computational study. RSC Advances. 3(43). 21106–21106. 3 indexed citations

12.

Josey, Benjamin J., Elizabeth S. Inks, Xuejun Wen, & C. James Chou. (2013). Structure–Activity Relationship Study of Vitamin K Derivatives Yields Highly Potent Neuroprotective Agents. Journal of Medicinal Chemistry. 56(3). 1007–1022. 65 indexed citations

13.

Inks, Elizabeth S., et al.. (2011). A Novel Class of Small Molecule Inhibitors of HDAC6. ACS Chemical Biology. 7(2). 331–339. 88 indexed citations

14.

Fisher, Mark, et al.. (2008). Testing intra-hemocelic injection of antimicrobials against Encephalitozoon sp. (Microsporidia) in an insect host. Parasitology Research. 104(2). 419–424. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact